CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
New Oral Agent for Treatment of Anemia in Patient with Chronic Kidney Disease: Prolyl Hydroxylase Inhibitor
KiRyang Na
Korean J Med. 2019;94(1):11-16.   Published online 2019 February 1    DOI: https://doi.org/10.3904/kjm.2019.94.1.11

Excel Download

New Oral Agent for Treatment of Anemia in Patient with Chronic Kidney Disease: Prolyl Hydroxylase Inhibitor
The Korean Journal of Medicine. 2019;94(1):11-16   Crossref logo
Link1 Link2 Link3

HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
Kidney International. 2016;90(5):923-925   Crossref logo
Link1 Link2

Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease
Kidney International. 2017;92(2):306-312   Crossref logo
Link1 Link2

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
American Journal of Kidney Diseases. 2017;69(6):815-826   Crossref logo
Link1 Link2

Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease?
Nephrology Dialysis Transplantation. 2019;   Crossref logo
Link1

253 Evaluation of FG-4592, a Novel Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, to Treat Anemia in Hemodialysis Patients
American Journal of Kidney Diseases. 2011;57(4):B80   Crossref logo
Link1 Link2

Anemia in the Kidney-Transplant Patient
Advances in Chronic Kidney Disease. 2006;13(1):4-10   Crossref logo
Link1 Link2

SP334IRON REGULATION BY MOLIDUSTAT, BAY 85-3934, A DAILY ORAL HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Nephrology Dialysis Transplantation. 2018;33(suppl_1):i457-i457   Crossref logo
Link1

Erratum Regarding “Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD” (Am J Kidney Dis. 2017;69[6]:815-826)
American Journal of Kidney Diseases. 2017;69(6):869   Crossref logo
Link1 Link2

Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease
Advances in Chronic Kidney Disease. 2004;11(2):143-161   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Med has participated in CrossRef Text and Data Mining service since September 11, 2015.